These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2390240)

  • 21. Changes in ocular blood flow and retinal oxygen metabolism during immunosuppressive therapy for initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; AlBloushi AF; Gikandi PW; Alzubaidi A; Stefánsson E
    Acta Ophthalmol; 2022 Sep; 100(6):707-712. PubMed ID: 35235253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
    Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.
    Errera MH; Fardeau C; Cohen D; Navarro A; Gaudric A; Bodaghi B; Westcott M; LeHoang P
    Acta Ophthalmol; 2011 Jun; 89(4):e357-66. PubMed ID: 21251241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusual case of vitiligo reversal in Vogt-Koyanagi-Harada syndrome.
    Subudhi P; Khan Z; Subudhi BNR; Sitaram S
    Indian J Ophthalmol; 2017 Sep; 65(9):867-868. PubMed ID: 28905833
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease.
    Sasamoto Y; Ohno S; Matsuda H
    Ophthalmologica; 1990; 201(3):162-7. PubMed ID: 2089358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
    Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
    BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vogt-Koyanagi-Harada syndrome: apropos of 2 cases].
    Gabsi S; Hassoumi MH; Doss N; Mejri A; Othmani S; Bahri M
    Tunis Med; 1989 Dec; 67(12):817-20. PubMed ID: 2623779
    [No Abstract]   [Full Text] [Related]  

  • 28. [Vogt-Koyanagi-Harada disease. Characteristics of a series of Andalusian patients].
    García Hernández FJ; Ocaña Medina C; Castillo Palma MJ; Sánchez Román J; Rueda Rueda T; Pulido Aguilera MC; López Checa F
    Rev Clin Esp; 2006 Sep; 206(8):388-91. PubMed ID: 16863625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TATTOO-ASSOCIATED CASES OF POSTERIOR SEGMENT UVEITIS WITH VOGT-KOYANAGI-HARADA DISEASE-LIKE FEATURES.
    Kesav NP; Kaplan AJ; Hwang CK; Okeagu C; Sen HN
    Retin Cases Brief Rep; 2022 Jul; 16(4):457-460. PubMed ID: 32502130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current aspects of the Vogt-Koyanagi-Harada syndrome. Apropos of 9 cases].
    Limon S; Girard P; Bloch-Michel E; Guillevin L; Forest A
    J Fr Ophtalmol; 1985; 8(1):29-35. PubMed ID: 2582026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vogt-Koyanagi-Harada syndrome Case report.
    Nicula C; Szabo I
    Rom J Ophthalmol; 2016; 60(3):181-183. PubMed ID: 29450345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posterior segment recurrences in Vogt-Koyanagi-Harada disease.
    Sachdev N; Gupta V; Gupta A; Singh R
    Int Ophthalmol; 2008 Oct; 28(5):339-45. PubMed ID: 17898934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD; Rathinam SR; Cunningham ET
    Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of immunosuppressive therapy on oxygen saturation and diameter of retinal vessels in initial onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Alotaibi MD; Gikandi PW; Stefánsson E
    Acta Ophthalmol; 2021 Feb; 99(1):75-82. PubMed ID: 32592327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vogt-Koyanagi-Harada syndrome in children - a case report].
    Bušányová B; Tomčíková D; Gerinec A
    Cesk Slov Oftalmol; 2013 Jun; 69(2):81-6. PubMed ID: 23964873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
    Gruich MJ; Evans OB; Storey JM; Bradley ST; Chen CJ
    Pediatr Neurol; 1995 Jul; 13(1):50-1. PubMed ID: 7575849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vogt-Koyanagi-Harada disease after stapedotomy.
    Accorinti M; Gilardi M; Nardella C; Amorelli GM; Pesci FR
    Eur J Ophthalmol; 2015 Oct; 25(6):e127-30. PubMed ID: 25982211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple recurrences of exudative retinal detachment in a patient with Vogt-Koyanagi-Harada disease.
    Garcia-Valenzuela E; Tessler HH; Carnahan M; Ryan JJ; Oldstein DA
    Retina; 2000; 20(6):672-4. PubMed ID: 11131425
    [No Abstract]   [Full Text] [Related]  

  • 39. Vogt-Koyanagi-Harada syndrome in children.
    Rathinam SR; Vijayalakshmi P; Namperumalsamy P; Nozik RA; Cunningham ET
    Ocul Immunol Inflamm; 1998 Sep; 6(3):155-61. PubMed ID: 9785605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term course of immunosuppressive therapy of Vogt-Koyanagi-Harada syndrome].
    Wand K; Abraham S; Loos D; Stumpfe S; Lohmann C; Maier M; Feucht N
    Ophthalmologe; 2015 Oct; 112(10):857-60. PubMed ID: 25680347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.